Management Team
Rebecca E. Caffrey, Ph.D., MBA
CEO & Head of Diagnostics Division
Dr. Caffrey has a PhD in Immunology was earned from the Medical College of Virginia.  She is a seasoned biotechnology executive and serial entrepreneur whose career has been focused on translational medicine via discovery and development of new biomarkers with therapeutic and diagnostic potential.  Dr. Caffrey has founded and worked in a number of biotechnology start-up companies with a diagnostic/personalized medicine focus. 

Dr. Eva Chin, PhD
Chief Scientific Officer
Dr. Chin has a Ph.D. from the University of Waterloo and 25 yrs research and development experience in metabolic and neuromuscular diseases.  She was a Principal Scientist and Associate Director with Pfizer R&D units prior to joining the School of Public Health at the University of Maryland.

Scientific Team
Dr. Alexandra McPherron, PhD
Principal Scientist and Head of Discovery
Dr. McPherron has a Ph.D. from The Johns Hopkins University School of Medicine and 20 years research experience in the area of  muscle growth & metabolism.  She is co-inventor on over a dozen patents related to the identification of Myostatin and methods of targeting the myostatin pathway.  Dr. McPherron is a former PI at NIH.

Research & Development for Muscle-Based Diseases